The CARTIHEAL Implant will be featured at the Arthroscopy Association of North America Annual Meeting (AANA 2025) this week Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces encouraging results for its CARTIHEAL AGILI-C Cartilage Repair Implant from a recent multicentre randomised controlled trial (RCT) treating knee cartilage defects. When compared to the current surgical standard of care,* the implant demonstrated: Superior pain relief: Patients treated with the CART ...

Meera Chandan AC (44-20) 7134-2924 meera.chandan@jpmorgan.com J.P. Morgan Securities plc Arindam Sandilya AC (65) 6882-7759 arindam.x.sandilya@jpmorgan.com JPMorgan Chase Bank, N.A., Singapore Branch Our bearish USD view thus far has not been motivated by expectations of any such accords; it is instead explained by underlying fundamentals — both cyclical and possibly structural. The USD weakness year-to-date thus far has been European-led and has not needed any such accords. The moti- vation for USD weaknes ...

Shares of Tesla, Inc. TSLA are trading lower Monday. But they continue to be in a sideways trend.A classic ‘Flag' pattern may have formed on the chart. If so, it could be bullish for the shares and suggest the recent uptrend may soon get back into gear. This is why we have made it our Stock of the Day.Many traders and investors were surprised and confused when Tesla rallied after posting disappointing earnings. They didn't understand why the stock moved higher. But it was simply the result of supply and dem ...

Core Viewpoint - Constellium SE reported solid financial results for Q1 2025 despite ongoing demand weakness in most end markets, with a focus on cost reduction and operational performance [2][3][4] Financial Performance - Q1 2025 shipments totaled 372 thousand metric tons, a decrease of 2% compared to Q1 2024 [4][43] - Revenue for Q1 2025 was $1.979 billion, representing a 5% increase from $1.880 billion in Q1 2024 [3][6] - Net income increased to $38 million in Q1 2025 from $22 million in Q1 2024 [3][14] - Adjusted EBITDA rose to $186 million in Q1 2025, up from $146 million in Q1 2024 [3][6] Segment Performance - Aerospace & Transportation (A&T) segment reported Adjusted EBITDA of $75 million, down 14% from $87 million in Q1 2024, with shipments decreasing by 11% [7] - Packaging & Automotive Rolled Products (P&ARP) segment saw Adjusted EBITDA increase by 25% to $60 million, with shipments up 2% [8] - Automotive Structures & Industry (AS&I) segment's Adjusted EBITDA fell 50% to $16 million, with shipments down 12% [9] Cash Flow and Capital Management - Cash from operations was $58 million, while Free Cash Flow was negative at $(3) million [15][16] - The company repurchased 1.4 million shares for $15 million during the quarter [5][17] - Leverage ratio stood at 3.3x as of March 31, 2025 [5] Outlook - The company maintains its guidance for 2025, expecting Adjusted EBITDA between $600 million and $630 million, and Free Cash Flow exceeding $120 million [2][20] - Long-term targets include Adjusted EBITDA of $900 million and Free Cash Flow of $300 million by 2028 [20]

MDU Resources Group (MDU) 2024 Investor Day March 13, 2024 11:00 AM ET Speaker0 All right. I think we'll go ahead and get started doing a mic check. Can everyone hear me? All right. Perfect. Okay. I want to welcome everyone to in the room as well as those joining via webcast to MD Resources Investor Day, and certainly thank you for your interest in our company. It truly is an exciting time for our company as we continue transforming our business. Before getting started, I'd like to take a few minutes to int ...